A team of Houston nurses won a national innovation award for a new game-changing training tool. Photos via Texas Children's Hospital

A team of Houston nurses was awarded the 2022 American Nursing Association Innovation Award last month for an engaging training tool that has already helped their peers locally and in sub-Saharan Africa become better equipped at performing essential medical skills.

Michael Pickett, Jaime Choate, and Jeannie Eggers with Texas Children's Hospital along with Marilyn Hocken and Tadala Mulemba with Baylor College of Medicine took home the nurse-led team award and $50,000 monetary prize for developing a group of devices known as the RediStik Wearable Simulation Trainers.

Resembling a CPR dummy and accompanied by immersive videos and live feedback via Zoom, the devices were designed to teach nurses how to insert Port-a-Cath and Central Venous Catheters (CVC) and perform peripheral intravenous (PIV) therapies, which are used to administer fluids, draw blood, and deliver medications.

The multidisciplinary team with support from the Texas Children’s Innovative Solutions Council developed five products (in two skin tones) over the course of three years that today can be worn by trainees and replicate textured skin and subcutaneous tissue to provide a realistic training experience.

The accompanying training materials and videos are often filmed from the nurse's point of view and are easily accessible via YouTube or a QR code.

The tools have already been utilized by nurses throughout Texas Children's, as well as in Sub-Saharan Africa through the hospital's partnership with the Global HOPE (Hematology Oncology Pediatric Excellence) initiative.

According to the ANA, after training with the RediStik devices, 96 percent of surveyed nurses reported that they felt confident in starting PIV lines, compared to only 15 percent of surveyed nurses prior to training.

The funds from the award will allow the RediStik team to distribute the devices to additional health care systems and nursing schools within Houston and internationally, according to a statement from ANA. Funds can also be used to support translational research, development, prototyping, production, testing, and the implementation of the technology.

The award winners—which also includes Kasheta Jackson of Vidant Health who took home the individual prize—have one year to further develop their products and report their outcomes.

The ANA innovation awards are sponsored by medical device company Stryker. The RediStik devices were engineered and produced by Sawbones, a Washington-based anatomical medical training models company.

February was a big month for Texas Children's and BCM.

In addition to the honor from the ANA, BCM Drs. Maria Elena Bottazzi and Peter Hotez, co-directors of the Center for Vaccine Development at Texas Children’s Hospital, were also nominated for the 2022 Nobel Peace Prize for their development of a low-cost COVID vaccine.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

5 Houston-area companies named among world's most innovative for 2026

In The Spotlight

Led by Conroe-based Hertha Metals, five organizations in the Houston area earned praise on Fast Company’s list of the World’s Most Innovative Companies of 2026.

Hertha Metals ranked No. 1 in the manufacturing category.

Last year, Hertha unveiled a single-step process for steelmaking that it says is cheaper, more energy-efficient and just as scalable as traditional steel manufacturing. It started testing the process in 2024 at a one-metric-ton-per-day pilot plant.

At the same time, Hertha announced more than $17 million in venture capital funding from investors such as Breakthrough Energy, Clean Energy Ventures, Khosla Ventures, and Pear VC.

“We’re not just reinventing steelmaking; we’re redefining what’s possible in materials, manufacturing, and national resilience,” Laureen Meroueh, founder and CEO of Hertha, said at the time.

Meroueh was also recently named to Inc. Magazine's 2026 Female Founders 500 list.

Hertha, founded in 2022, says traditional steelmaking relies on an outdated, coal-based multistep process that is costly, and contributes up to 9 percent of industrial energy use and 10 percent of global carbon emissions.

By contrast, Hertha’s method converts low-grade iron ore into molten steel or high-purity iron in one step. The company says its process is 30 percent more energy-efficient than traditional steelmaking and costs less than producing steel in China.

Last year, Hertha said it planned to break ground in 2026 on a plant capable of producing more than 9,000 metric tons of steel per year. In its next phase, the company plans to operate at 500,000 metric tons of steel production per year.

Here are Fast Company’s rankings for the four other Houston-area organizations:

  • Houston-based Vaulted Deep, No. 3 in catchall “other” category.
  • XGS Energy, No. 7 in the energy category. XGS’ proprietary solid-state geothermal system uses thermally conductive materials to deliver affordable energy anywhere hot rock is located. While Fast Company lists Houston as XGS’ headquarters, and the company has a major presence in the city, XGS is based in Palo Alto, California.
  • Houston-based residential real estate brokerage Epique Realty, No. 10 in the business services category. Epique, which bills itself as the industry’s first AI brokerage, provides a free AI toolkit for real estate agents to enhance marketing, streamline content creation, and improve engagement with clients and prospects.
  • Texas A&M University’s Nanostructured Materials Lab in College Station. The lab studies nano-structured materials to make materials lighter for the aerospace industry, improve energy storage, and enable the creation of “smart” textiles.
---

This article first appeared on our sister site, EnergyCapitalHTX.com.

UH lands $11.8M for first-of-its-kind early language development study

speech funding

Researchers at the University of Houston have secured an $11.8 million grant from the National Institutes of Health to conduct a first-of-its-kind study of early language development.

Led by Elena Grigorenko, the Hugh Roy and Lillie Cranz Cullen Distinguished Professor of Psychology, and research professor Jack Fletcher, the study will follow 3,600 children aged 18 to 24 months to uncover how language skills develop at this critical stage and why some children experience delays that can influence later growth.

The NIH funding will also support the development of the new national Clinical Research Center on Developmental Language Disorders at UH, which aims to bring experts from psychology, education, health and measurement sciences to study how children learn language.

“This will be the first national study to estimate how common late talking is using a large, representative sample of Houston toddlers,” Grigorenko said in a news release. “By following these children as they grow, we hope to better understand the developmental pathways that can lead to conditions such as developmental language disorder and autism.”

UH’s team will partner with the pediatric clinic network at Texas Children’s Hospital, where children will be screened for early language development, allowing researchers to identify those who show signs of delayed speech. Next, researchers will follow the cohort through early childhood to examine how language abilities evolve and how early delays may lead to later challenges.

The Clinical Research Center on Developmental Language Disorders will be the 14th national research center established at UH, and will include researchers from multiple UH departments, as well as partners at Baylor College of Medicine and the Texas Center for Learning Disorders.

“This level of investment from the National Institutes of Health reflects the significance of this work to address a complex challenge affecting children, families and communities,” Claudia Neuhauser, vice president for research at UH, said in a news release. “By bringing together experts from multiple disciplines and partnering with major health systems across the region, the project reflects our commitment to advancing discoveries that impact our community.”

Rice Alliance names Houston healthtech exec as first head of platform

new hire

The Rice Alliance for Technology and Entrepreneurship has named its first head of platform.

Houston entrepreneur Laura Neder stepped into the newly created role last month, according to an email from Rice Alliance. Neder will focus on building and growing Houston’s Venture Advantage Platform.

The emerging platform, which is being promoted by Rice Alliance and the Ion, aims to connect founders with the "people, capital and expertise they need to scale."

"I’ve spent a lot of time thinking about what it takes to make an innovation ecosystem more navigable, more connected, and more useful for founders," Neder said in a LinkedIn post. "I’m grateful for the opportunity to do that work at Rice Alliance, alongside a team with a long history of supporting entrepreneurship and innovation."

"Houston has the talent, institutions, and industry base to create real advantage for founders," she added. "I’m looking forward to listening, learning, and building stronger pathways across the ecosystem."

Neder most recently served as CEO of Houston-based Careset, where she helped bring the Medicare data startup to commercialization. Prior to that, Neder served as COO of Houston-based telemedicine startup 2nd.MD, which was acquired for $460 million by Accolade in 2021.

"Laura brings a rare combination of founder empathy, operational experience and ecosystem leadership," Rice Alliance shared.

Neder and Rice Alliance also shared that the organization is hiring developers to design the new Venture Advantage Platform. Learn more here.